Chemotherapy combined with radiotherapy is the traditional treatment for oropharyngeal cancer. All cancer treatments ... therapy to the patient’s stage and HPV status, as HPV-positive and ...

In 2011, the then 51-year-old was diagnosed with stage four oropharyngeal cancer. “I’d never been a smoker or a drinker, let ...

NPG-2044 is under clinical development by Novita Pharmaceuticals and currently in Phase II for Oropharyngeal Cancer.

Atezolizumab is under clinical development by F. Hoffmann-La Roche and currently in Phase II for Oropharyngeal Cancer.

Medically reviewed by William Truswell, MD Lip cancer is an oral cancer that first develops on the lips, usually causing an ...

Oropharyngeal cancer (OPC) rates are rising among people living with HIV, and Bansal is determined to find out why by exploring how chronic HIV infection influences appears to drive development of ...

EnnoDC presents preliminary data for immunotherapy candidate CD40.HVac in HPV+ oropharyngeal cancer at ESMO IO 2024 Paris, France, 9 December 2024 – EnnoDC, a clinical-stage biotech company ...

The Company currently has three active clinical trials in various stages of clinical development, addressing oncology and infectious disease indications. Its lead asset, CD40HVac is currently in a ...